Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment-Reference-Cited by-同舟云学术

Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment

Published:2015-06-22 Issue:7 Volume:90 Page:647-652
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Zannetti Beatrice Anna¹,Zamagni Elena¹,Santostefano Marisa²,De Sanctis Lucia Barbara²,Tacchetti Paola¹,Mancini Elena²,Pantani Lucia¹,Brioli Annamaria¹,Rizzo Raffaella²,Mancuso Katia¹,Rocchi Serena¹,Pezzi Annalisa¹,Borsi Enrica¹,Terragna Carolina¹,Marzocchi Giulia¹,Santoro Antonio²,Cavo Michele¹

Affiliation:

1. “Seràgnoli” Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine Bologna, University School of Medicine, Sant'Orsola-Malpighi University Hospital; Bologna Italy

2. Nephrology, Dialysis; and Hypertension Unit; Sant'Orsola-Malpighi University Hospital; Bologna Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24035/fullpdf

Reference32 articles.

1. Renal impairment in patients with multiple myeloma: A consensus statement on behalf of the international myeloma working group;Dimopoulos;J Clin Oncol,2010

2. Management of myeloma-associated renal dysfunction in the era of novel therapies;Gaballa;Expert Rev Hematol,2012

3. Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment;Chanan-Khan;Clin Cancer Res,2012

4. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma;Hutchison;Nat Rev Nephrol

5. Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom medical research council trials between 1980 and 2002-Medical research council adult leukaemia working party;Augustson;J Clin Oncol,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era;Clinical and Experimental Medicine;2024-09-09

2. Treatment outcomes of multiple myeloma in patients requiring renal replacement therapy;Journal of Renal Injury Prevention;2024-04-04

3. Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study;Frontiers in Oncology;2023-09-08

4. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group;The Lancet Oncology;2023-07

5. Management of Renal Failure in Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15